Desmopressin Acetate Injection, Solution
Product Images NDC 25021-461

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Desmopressin Acetate (NDC 25021-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Des05 0001 01)

Chemical structure of desmopressin acetate shown as a peptide sequence with molecular components including side chains and atoms, labeled with positions 1 through 9, along with associated acetic acid and water molecules.*

FDA Label Image

Des05 0003 02

Label for Desmopressin Acetate Injection, USP by Sagent Pharmaceuticals. The solution is 40 mcg per 10 mL (4 mcg per mL) for intravenous or subcutaneous use. The vial contains 10 mL, is sterile and nonpyrogenic. Storage conditions indicated are between 2° and 8°C (36° and 46°F). The label includes warnings and dosage instructions and displays the NDC 25021-461-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.